Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares, rose in value on Thursday, July 10, with the stock price up by 5.61% to the previous day’s close as strong demand from buyers drove the stock to $1.13.
Actively observing the price movement in the last trading, the stock closed the session at $1.07, falling within a range of $1.07 and $1.19. The value of beta (5-year monthly) was 1.008. Referring to stock’s 52-week performance, its high was $2.45, and the low was $0.28. On the whole, LXRX has fluctuated by 51.66% over the past month.
With the market capitalization of Lexicon Pharmaceuticals Inc currently standing at about $410.39 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 4.87M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that LXRX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of LXRX currently trading nearly 34.97% and 54.87% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 72.74, while the 7-day volatility ratio is showing 10.38% which for the 30-day chart, stands at 9.88%. Furthermore, Lexicon Pharmaceuticals Inc (LXRX)’s beta value is 1.17.
A comparison of Lexicon Pharmaceuticals Inc (LXRX) with its peers suggests the former has fared considerably weaker in the market. LXRX showed an intraday change of 5.61% in last session, and over the past year, it grew by 53.01%%.
Data on historical trading for Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) indicates that the trading volumes over the past 10 days have averaged 6.01 and over the past 3 months, they’ve averaged 5.01 million. According to company’s latest data on outstanding shares, there are 363.18 million shares outstanding.
Nearly 51.26% of Lexicon Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 26.49% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 37.56 million shares as on 2025-06-13, resulting in a short ratio of 9.39. According to the data, the short interest in Lexicon Pharmaceuticals Inc (LXRX) stood at 2891.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 43.03 million. The stock has fallen by -32.34% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the LXRX stock heading into the next quarter.
